Guselkumab dosing interval optimization in adult patients with moderate-to-severe psoriasis switching from ustekinumab

  1. Ruiz-Villaverde, R.
  2. Chinchay, F.V.
  3. Rodriguez-Fernandez-Freire, L.
  4. Armario-Hita, J.C.
  5. Pérez-Gil, A.
  6. Galán-Gutiérrez, M.
Aldizkaria:
Dermatologic Therapy

ISSN: 1529-8019 1396-0296

Argitalpen urtea: 2022

Alea: 35

Zenbakia: 11

Mota: Artikulua

DOI: 10.1111/DTH.15835 GOOGLE SCHOLAR

Objetivos de desarrollo sostenible